TY - JOUR
T1 - Bilateral Risk Assessments of Surgery and Nonsurgery Contribute to Providing Optimal Management in Early Gastric Cancers after Noncurative Endoscopic Submucosal Dissection
T2 - A Multicenter Retrospective Study of 485 Patients
AU - Koizumi, Eriko
AU - Goto, Osamu
AU - Takizawa, Kohei
AU - Mitsunaga, Yutaka
AU - Hoteya, Shu
AU - Hatta, Waku
AU - Masamune, Atsushi
AU - Osawa, Satoshi
AU - Takeuchi, Hiroya
AU - Suzuki, Sho
AU - Omori, Jun
AU - Ikeda, Go
AU - Habu, Tsugumi
AU - Ishikawa, Yumiko
AU - Kirita, Kumiko
AU - Noda, Hiroto
AU - Higuchi, Kazutoshi
AU - Onda, Takeshi
AU - Akimoto, Teppei
AU - Akimoto, Naohiko
AU - Kaise, Mitsuru
AU - Iwakiri, Katsuhiko
N1 - Funding Information:
This study was supported by a JFE (The Japanese Foundation for Research and Promotion of Endoscopy) Grant in 2019.
Publisher Copyright:
© 2022 S. Karger AG, Basel. All rights reserved.
PY - 2022/7/1
Y1 - 2022/7/1
N2 - Background and Aims: Surgery is recommended in early gastric cancer (EGC) after noncurative endoscopic submucosal dissection (ESD), although observation can be an alternative. We aimed to develop a tailor-made treatment strategy for noncurative EGCs by comparing the lymph node metastasis risk (LNMR) and the surgical risk. Methods: We retrospectively identified 485 patients with differentiated-type, noncurative EGCs removed by ESD and classified them into two groups: A surgery-preferable group and an observation-preferable group, according to the clinical courses. Subsequently, LNMR and surgery-related death risk were assessed using a published scoring system and a risk calculator for gastrectomy, respectively. Finally, we investigated the optimal cutoff value of the risk difference (LNMR minus surgery-related death risk) to efficiently allocate these cases into either of two groups, surgery-preferable or observation-preferable. Results: In 485 patients (surgery in 322, observation in 163), 57 and 428 patients were classified into the surgery-preferable group and the observation-preferable group, respectively. The optimal cutoff value of the risk difference (LNMR minus surgery-related death risk) to allocate the cases to the two preferable groups was 7.85 with the highest area under the curve (0.689). When cases with >7.85 LNMR over the surgery-related death risk were allocated into the surgery-preferable group and vice versa, the discriminability was 73.2%, which was sufficiently higher than that in the clinical decision (44.5%). Conclusion: Personalized comparison of LNMR and surgery-related death risk is helpful to provide a favorable treatment option for each patient with EGCs after noncurative ESD.
AB - Background and Aims: Surgery is recommended in early gastric cancer (EGC) after noncurative endoscopic submucosal dissection (ESD), although observation can be an alternative. We aimed to develop a tailor-made treatment strategy for noncurative EGCs by comparing the lymph node metastasis risk (LNMR) and the surgical risk. Methods: We retrospectively identified 485 patients with differentiated-type, noncurative EGCs removed by ESD and classified them into two groups: A surgery-preferable group and an observation-preferable group, according to the clinical courses. Subsequently, LNMR and surgery-related death risk were assessed using a published scoring system and a risk calculator for gastrectomy, respectively. Finally, we investigated the optimal cutoff value of the risk difference (LNMR minus surgery-related death risk) to efficiently allocate these cases into either of two groups, surgery-preferable or observation-preferable. Results: In 485 patients (surgery in 322, observation in 163), 57 and 428 patients were classified into the surgery-preferable group and the observation-preferable group, respectively. The optimal cutoff value of the risk difference (LNMR minus surgery-related death risk) to allocate the cases to the two preferable groups was 7.85 with the highest area under the curve (0.689). When cases with >7.85 LNMR over the surgery-related death risk were allocated into the surgery-preferable group and vice versa, the discriminability was 73.2%, which was sufficiently higher than that in the clinical decision (44.5%). Conclusion: Personalized comparison of LNMR and surgery-related death risk is helpful to provide a favorable treatment option for each patient with EGCs after noncurative ESD.
KW - Endoscopic submucosal dissection
KW - Gastric cancer
KW - Lymph node metastasis
KW - Noncurative resection
KW - Surgical risk
UR - http://www.scopus.com/inward/record.url?scp=85130447796&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85130447796&partnerID=8YFLogxK
U2 - 10.1159/000523972
DO - 10.1159/000523972
M3 - Article
C2 - 35512657
AN - SCOPUS:85130447796
SN - 0012-2823
VL - 103
SP - 296
EP - 307
JO - Digestion
JF - Digestion
IS - 4
ER -